Date: 30.7.2018
Summary:
A Spanish Research Public Organization has developed a peptide capable of inhibiting the signaling of Interleukin 13 mediated by interleukin 13 receptor The peptide alone or within a nanoparticle or virus-like particles can be used in a pharmaceutical composition for the treatment of pathologies in which it is overexpressed: control of metastasis of colon cancer and other tumors (i.e glioblastoma), asthma, atopic dermatitis or fibrosis. Industrial partners are being sought for licence agreement.
Reference: TOES20180117001
Country: Spain
Submitted: 30. 7. 2018
Keywords
Technology: Cytology, Cancerology, Oncology; Medical Research, Pharmaceutical Products / Drugs
Market: Pulmonary medicine, Oncology
NACE: Research and experimental development on biotechnology
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Science Blogs - Blogs about science: Medicine, Biology, Physical science, ...
Biotech - International biotech science
Grow a pair: Lab-grown testicles tackle infertility treatment
A single dose of urea-powered nanorobots reduces bladder tumors by 90% in mouse study